HOUT-11. EXTENSIVE BRAINSTEM INFILTRATION, NOT MASS EFFECT, IS A COMMON FEATURE OF END-STAGE CEREBRAL GLIOBLASTOMAS

BACKGROUND: Progress in extending the survival of glioblastoma (GBM) patients has been slow, suggesting that preclinical and clinical trial approaches may not fully take into account the nature of this cancer. A better understanding of why GBM patient survival remains poor is critical to developing...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Neuro Oncol
Autors principals: Drumm, Michael, Dixit, Karan, Grimm, Sean, Kumthekar, Priya, Lukas, Rimas, Raizer, Jeffrey, Kam, Kwok-Ling, McCord, Matthew, Sachdev, Sean, Kruser, Timothy, Steffens, Alicia, Javier, Rodrigo, McCortney, Kathleen, Horbinski, Craig
Format: Artigo
Idioma:Inglês
Publicat: Oxford University Press 2019
Matèries:
Health Outcome Measures
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847675/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.476
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars